Grilling the meat substantially boosted detection of the prions, which the authors say may be because heat helps release prions trapped in the tissue.
Watch a webinar on findings and recommendations from CIDRAP's report on CWD spillover preparedness and response. Experts discuss key One Health topics followed by a Q&A session moderated by CIDRAP Director Dr. Michael Osterholm.
The report provides useful guidance to professionals at human, animal, and wildlife health agencies; academic researchers; and medical practitioners who will be tasked with responding to any human or non-cervid animal chronic wasting disease spillover.
The CIDRAP CWD Resource Center hosts webinars featuring natural and international experts.
Our monthly roundup features the latest CWD-related news, research, and events.
Stay in touch with CIDRAP CWD via X for the latest news and research.
Keep current with CIDRAP CWD news and research on Bluesky.
Receive CWD updates in your inbox
Chronic wasting disease (CWD) has been confirmed for the first time in Louisiana, the Louisiana Department of Wildlife and Fisheries (LDWF) said late last week.
Needless insurer spending on ivermectin prescriptions for COVID-19, estimated at $2.5 million in the United States for the week of Aug 13, 2021—the most recent week analyzed—would extrapolate to $130 million annually, US researchers reported yesterday in JAMA.
The Arkansas Game and Fish Commission (AGFC) recently announced the first positive chronic wasting disease (CWD) test in a hunter-harvested deer in Union County, far from the nearest known positive finding in the state.
During a meeting tomorrow at the Radiological Society of North America (RSNA), scientists will present data from the largest multi-institutional international study to date on brain complications of COVID-19 and share that 1 in 100 patients hospitalized with COVID-19 will likely develop complications of the central nervous system like stroke, hemorrhage, and other potentially fatal complications.
The corticosteroid dexamethasone was associated with a 56% lower risk of death and intensive care unit (ICU) admission among hospitalized COVID-19 patients and is safe to use in monitored diabetes patients, according to research presented at this week's Society for Endocrinology annual conference in Edinburgh, Scotland.
A new report from the Centers for Disease Control and Prevention (CDC) shows that progress against healthcare-associated infections (HAIs), including those caused by antibiotic-resistant bacteria, took a step back in 2020.
Two doses of the Pfizer/BioNTech and Moderna mRNA COVID-19 vaccines were 93% and 96% effective, respectively, in preventing severe, critical, or fatal disease caused by the highly transmissible Delta (B1617.2) variant, a study today in Nature Medicine finds.
A third Pfizer COVID-19 vaccine dose is 92% more effective in reducing severe COVID-related outcomes than two doses of the same vaccine received at least 5 months previously, according to a large real-world study late last week in The Lancet.
First responders' risk for COVID-19 infection is about 60% more than other essential workers, including healthcare workers (HCWs), according to a study published late last week in JAMA Health Forum.
People with mental disorders and intellectual disabilities had a greater mortality risk during the COVID-19 pandemic in 2020, according to a study published late last week in The Lancet Regional Health – Europe.